(*) Leider ist diese Information in Deutsch nicht verfügbar.
Workload
Form der Prüfung
Ausbildungslevel
Studienfachbereich
VerantwortlicheR
Anbietende Uni
3 ECTS
Kumulative Modulprüfung
B2 - Bachelor 2. Jahr
Biologische Chemie
Eva Benesova
USB Budweis
Detailinformationen
Quellcurriculum
Bachelorstudium Biological Chemistry 2025W
Lernergebnisse
Kompetenzen
(*)The objective of this course is to give basic overview of current trends in biopharmaceuticals. The focus will be on 3 aspects of this broad theme: a) the use of living cell as a production apparatus b) on physiology principles of current biotechnology drugs c) practical examples of current biopharmaceuticals.
The course is focused on the field of pharmaceuticals which are produced by biotechnology approaches with the use of genetically modified both prokaryotic and eukaryotic organisms. In the opening parts, students will gain the basic information on the way of production of these biological drugs together with a basic information on related regulatory affairs. The course will then analyze differences between biological drugs and classical synthetic ones. After this introduction the main groups of indications and individual drugs will be presented. The aim of this part is good understanding of mechanism of action of these drugs and possible risk factors.
To give students basic information on this field of biological pharmaceuticals which represent currently most dynamic developing filed of pharmaceuticals. To give overview of current drugs, their structure, production and biological effects.
Basic principles of human patho-physiology will explained to reflect the mechanism of action of these drugs. In the last part of lectures students will prepare their own presentation on given themes so they will be actively participating in the lectures and discussions. The program of the course is based upon similar program already running at the VSCHT by the same lecturer.
Fertigkeiten
Kenntnisse
(*)Students will know and understand the methods used in biopharmaceutics (k1, k2) and will be able to apply this knowledge for the design of needed methods in a study of a biopharmaceutical (k3, k6).
(*)1. Introduction: What is bio-pharmacy, history of biotechnology, current trends.
2. General steps in drug development: Pre-clinical and clinical phases, regulatory principles, costs of development.
3. Bio-macromolecules: A structural and functional view.
4. Analysis of bio-macromolecules - Analytical techniques used for determination of purity of biopharmaceuticals.
5. Differences between procaryotic and eucaryotic cells - Important differences for production of drugs.
6. Isolation of products - Major techniques of industrial isolation of bio-macromolecules.
7. Major drugs - hormones and cytokines
8. Major drugs - enzymes
9. Major drugs - vaccines
10. Major drugs - antibodies
11. Gene therapies
12. Safety of drugs and development of generic biopharmaceuticals.
13. Commercial aspects of this field.
14. Future directions and few comments on ethical issues.
Sonstige Informationen
(*)1. Introduction: What is bio-pharmacy, history of biotechnology, current trends.
2. General steps in drug development: Pre-clinical and clinical phases, regulatory principles, costs of development.
3. Bio-macromolecules: A structural and functional view.
4. Analysis of bio-macromolecules - Analytical techniques used for determination of purity of biopharmaceuticals.
5. Differences between procaryotic and eucaryotic cells - Important differences for production of drugs.
6. Isolation of products - Major techniques of industrial isolation of bio-macromolecules.
7. Major drugs - hormones and cytokines
8. Major drugs - enzymes
9. Major drugs - vaccines
10. Major drugs - antibodies
11. Gene therapies
12. Safety of drugs and development of generic biopharmaceuticals.
13. Commercial aspects of this field.
14. Future directions and few comments on ethical issues.
Äquivalenzen
(*)ANTBICEBIPV10: VO Biopharmacy (3 ECTS) (as lecture)
Untergeordnete Studienfächer, Module und Lehrveranstaltungen